Sustainability goal indicators

in page functions

To improve sustainability of national immunisation programmes

Countries on track to successful transition

What we measure: the percentage of countries in the accelerated transition phase that are on track for a successful transition. A country is on track if:

  • it shows substantial progress in implementing its transition plan (that is, at least 75% of milestones and activities, such as having a functional national regulatory agency, have been completed on time);
  • its coverage with the third dose of diphtheria-tetanus-pertussis vaccine (DTP3) has increased over the last three years (if the country has already reached DTP3 coverage of at least 90%, it should have sustained this level for three years); and
  • it is meeting its co-financing obligations and did not default on its payments in the previous year.


What we measure: the percentage of countries that fulfill their co-financing commitments by the end of the year, or who pay their arrears in full within 12 months.

Where necessary, we adapt our deadlines to countries with a different fiscal cycle, such as Kenya and Pakistan.

Country investments in routine immunisation

What we measure: the percentage of countries that have increased their investment in routine immunisation per child, relative to 2015.

This indicator covers every vaccine in a country’s national programme, not just those supported by Gavi. It also includes expenditure on related 85% products beyond vaccines, such as injection supplies.

Institutional capacity

What we measure: the percentage of Gavi-supported countries that meet our minimum criteria for national decision-making, programme management and monitoring.

Strong institutional capacity is vital if a country’s Expanded Programme on Immunization (EPI) is to become programmatically and financially sustainable. This indicator assesses the performance and effectiveness of key immunisation management bodies such as the EPI, national immunisation technical advisory groups (NITAGs) and inter-agency coordination committees (ICCs).


>2 million

Since its creation in 2013, the global oral cholera vaccine stockpile has been used to vaccinate more than 2 million people. In 2016, eight countries – the Democratic Republic of the Congo, Haiti, Mozambique, Malawi, Niger, Somalia, South Sudan and Zambia – accessed the stockpile.


More facts...

close icon

modal window here